Market Analysis - Monthly Report - August, 2020 - Azithromycin
Overview of the Current Market Situation
In August, the price of Azithromycin remained stable at a high level. Price rose at the end of August because of exchange rate changing. In mid-August, some suppliers stopped production for maintenance, and the maintenance will last for one month. Therefore, the operating rate of suppliers has declined. Most suppliers still have no inventory and a backlog of orders. On the market side, the domestic trade market demand decreased. Demand in the foreign trade market has increased because of the continuation of the epidemic. The supply of upstream raw material Erythromycin thiocyanate is tight and prices are rising. Therefore, the price of azithromycin remained high and stable in August.

- Manufacturer Price and Production Situation Statistics
Factory Name |
Quotation (USD/KG) |
Change (from last week) |
Plant capacity |
GUOBANG |
/ |
Stable |
500MT/YEAR |
CSPC |
121 |
Stable |
500MT/YEAR |
HEC |
121 |
Decline |
150MT/YEAR |
SHIXING |
123 |
Stable |
300MT/YEAR |
QIYUAN |
121 |
Stable |
200MT/YEAR |
GUOLONG |
121 |
Stable |
200MT/YEAR |
TAIYICIN |
120 |
Stable |
150MT/YEAR |
DONGFENG |
120 |
Stable |
150MT/YEAR |

- Forecast of the Future Market Situation
Influential Factors |
Overview |
Price Trend |
Factory operating rate, inventory and cargo situation |
In September, the factory operating rate will pick up. The overhaul of equipment from most manufacturers will end. |
Decline |
Market Demand |
In the international market, due to the expansion of the epidemic, demand continued to rise. But the demand in China has decreased. |
Stable |
Market Sentiment |
Prices are currently high, and customers generally do not make inventory. Most are timely purchases when there is demand. |
Stable |
Factory determination to raise prices |
The factory will continue to maintain high prices. Because of the low operating rate |
Stable |
Upstream raw materials |
The price of Erythromycin Thiocyanate supply is tight, prices will rise in September. |
increase |
Industry event |
/ |
/ |
In conclusion |
In September, the factory operating rate will remain normal. Demand remains stable. The price of upstream raw material erythromycin thiocyanate is expected to rise. Therefore, the price of azithromycin stabilized in September. |
Stable |
2026-09-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China’s Acrylic Emulsion Leaders Raise Prices by Up to 15% as Monomer Costs Surge
-
Egyptian Pharmaceutical Market Research
-
CPHI China 2023 | At the Heart of Pharma
-
A Guide Into What the Pharmaceutical Use of Hexamine Is
-
In line with the 8201, Hengrui Pharmaceutical plans the HER2 ADC in this way
-
$50 billion in products were 'returned' to rationalize those blockbuster BD deals
-
Tronsound long-acting IL-36R antibody obtained FDA clinical IND
-
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure
-
The FDA accepted Zuranolone's NDA application and granted it priority review rights for the treatment of MDD and PDD
-
Asia Hong Pharma announced that it has co-developed an innovative tumor therapy based on AI+RNA technology route with ReviR
Recommend Reading
-
Business Society’s Market Outlook for Methanol on August 13, 2026: Clearly Upward Trend
-
Business Society’s Market Outlook for Caustic Soda on August 18, 2026: Fluctuating Trend
-
Consumption Fails to Match High Supply, October PP Refutes Peak Season Trend in China
-
Business Society’s Market Outlook for Petroleum Coke on August 11, 2026: Volatile
-
Both Supply and Demand Weak, Hydrogen Peroxide Prices Continue to Decline
-
Isopropyl Alcohol (IPA) vs Ethanol: Which Solvent or Disinfectant is Better?
-
Premium Global Chemical Sourcing Requests (26 - 29 Mar, 2026)
-
Premium Global Chemical Sourcing Requests (19 - 23 Jan, 2026)
-
Premium Global Chemical Sourcing Requests (3-5Aug, 2026)
-
Premium Global Chemical Sourcing Requests (3-7 Jan, 2026)